Your browser doesn't support javascript.
loading
Pattern recognition of microcirculation with super-resolution ultrasound imaging provides markers for early tumor response to anti-angiogenic therapy.
Yin, Jingyi; Dong, Feihong; An, Jian; Guo, Tianyu; Cheng, Heping; Zhang, Jiabin; Zhang, Jue.
Affiliation
  • Yin J; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
  • Dong F; College of Future Technology, Peking University, Beijing, China.
  • An J; State Key Laboratory of Membrane Biology, Peking-Tsinghua Center for Life Sciences, and Institute of Molecular Medicine, Peking University, Beijing, China.
  • Guo T; National Biomedical Imaging Center, Peking University, Beijing, China.
  • Cheng H; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
  • Zhang J; College of Future Technology, Peking University, Beijing, China.
  • Zhang J; College of Future Technology, Peking University, Beijing, China.
Theranostics ; 14(3): 1312-1324, 2024.
Article in En | MEDLINE | ID: mdl-38323316
ABSTRACT
Rationale Cancer treatment outcome is traditionally evaluated by tumor volume change in clinics, while tumor microvascular heterogeneity reflecting tumor response has not been fully explored due to technical limitations.

Methods:

We introduce a new paradigm in super-resolution ultrasound imaging, termed pattern recognition of microcirculation (PARM), which identifies both hemodynamic and morphological patterns of tumor microcirculation hidden in spatio-temporal space trajectories of microbubbles.

Results:

PARM demonstrates the ability to distinguish different local blood flow velocities separated by a distance of 24 µm. Compared with traditional vascular parameters, PARM-derived heterogeneity parameters prove to be more sensitive to microvascular changes following anti-angiogenic therapy. Particularly, PARM-identified "sentinel" microvasculature, exhibiting evident structural changes as early as 24 hours after treatment initiation, correlates significantly with subsequent tumor volume changes (|r| > 0.9, P < 0.05). This provides prognostic insight into tumor response much earlier than clinical criteria.

Conclusions:

The ability of PARM to noninvasively quantify tumor vascular heterogeneity at the microvascular level may shed new light on early-stage assessment of cancer therapy.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Theranostics Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Theranostics Year: 2024 Type: Article Affiliation country: China